Blog

Month: July 2016

Toronto, Ontario – July 29, 2016 – NOVADAQ Technologies Inc. (“NOVADAQ” or the “Company”) (NASDAQ:NVDQ; TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, announced today that management will participate in two investor conferences in August. Canaccord Genuity 36th Annual Growth Conference: NOVADAQ is scheduled to present on … Continue reading “NOVADAQ to Participate in August Investor Conferences”

Toronto, Ontario – July 27, 2016 – NOVADAQ Technologies Inc. (“NOVADAQ” or the “Company”) (NASDAQ:NVDQ; TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, today announced financial results for its second quarter ended June 30, 2016. Unless otherwise indicated, all dollar amounts in this press release are expressed … Continue reading “NOVADAQ Reports Second Quarter 2016 Financial Results”

Toronto, Ontario – July 11, 2016 – NOVADAQ Technologies Inc. (“NOVADAQ” or the “Company”) (NASDAQ:NVDQ; TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, will announce financial results for the second quarter of 2016 after market close on Wednesday, July 27, 2016. NOVADAQ President and CEO, Rick Mangat … Continue reading “NOVADAQ to Release Second Quarter 2016 Financial Results on July 27, 2016 – Conference Call to Follow”

Toronto, Ontario – July 6, 2016 – NOVADAQ® Technologies Inc. (“NOVADAQ” or the “Company”) (NASDAQ:NVDQ; TSX:NDQ), the leading developer and provider of clinically relevant imaging solutions for use in surgical and diagnostic procedures, announced today the appointment of Rick Mangat, Ph.D. as its President and CEO. Dr. Mangat succeeds Arun Menawat, who has resigned as the Company’s President, … Continue reading “NOVADAQ Announces Appointment of Rick Mangat as President and CEO”